Publicacións (41) Publicacións nas que participase algún/ha investigador/a

2011

  1. "Todo médico tiene un poco de brujo, en el buen sentido de la palabra": entrevista Rafael López López

    Galegos = Gallegos, Núm. 15, pp. 18-21

  2. 1ª guía de cáncer hereditario: Galicia

    Sociedad Oncológica de Galicia

  3. A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: Results from a phase II study

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 686-691

  4. A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues

    Proteomics, Vol. 11, Núm. 12, pp. 2555-2559

  5. A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)

    Investigational New Drugs, Vol. 29, Núm. 5, pp. 1038-1044

  6. Cavitaciones pulmonares múltiples

    Galicia Clínica, Vol. 72, Núm. 3, pp. 148

  7. Disease-free survival of colorectal cancer patients in relation to CDw75 antigen expression

    Pathobiology, Vol. 78, Núm. 4, pp. 201-209

  8. Evaluación ecónomica de capecitabina + cisplatino frente a 5-FU + cisplatino en el tratamiento en primera línea de cáncer gástrico avanzado en España

    Pharmacoeconomics - Spanish Research Articles, Vol. 8, Núm. 2, pp. 51-58

  9. Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 16, pp. 2433-2439

  10. Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study

    Cancer Genomics and Proteomics, Vol. 8, Núm. 2, pp. 93-101

  11. Fine mapping of a major histocompatibility complex in ankylosing spondylitis: Association of the HLA-DPA1 and HLA-DPB1 regions

    Arthritis and Rheumatism, Vol. 63, Núm. 11, pp. 3305-3312

  12. Fructose transporter GLUT5 expression in clear renal cell carcinoma

    Oncology Reports, Vol. 25, Núm. 2, pp. 315-323

  13. Generation of daughter cells in their niche

    Daughter Cells: Properties, Characteristics and Stem Cells (Nova Science Publishers, Inc.), pp. 163-196

  14. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry

    Breast Cancer Research and Treatment, Vol. 128, Núm. 2, pp. 573-579

  15. Hakai reduces cell-substratum adhesion and increases epithelial cell invasion

    BMC Cancer, Vol. 11

  16. High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion

    Molecular Cancer Therapeutics, Vol. 10, Núm. 8, pp. 1357-1366

  17. Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer

    BMC Cancer, Vol. 11

  18. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    Nature Genetics, Vol. 43, Núm. 8, pp. 761-767

  19. International distribution and age estimation of the Portuguese BRCA2 c.156-157insAlu founder mutation

    Breast Cancer Research and Treatment, Vol. 127, Núm. 3, pp. 671-679

  20. Low penetrance hereditary retinoblastoma in a family: What should we consider in the genetic counselling process and follow up?

    Familial Cancer